The currently ongoing, prospective PSMA-SRT study evaluates the success rate of sRT for recurrence of PCa after prostatectomy with and without planning based on PSMA-PET/CT [12], and this study includes patients with PSA > 0.1 ng/ml. Here, FOLH1 is linked to posterior cortical atrophy.